{\rtf1\ansi\ansicpg1252\cocoartf2822
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 paper_title: Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned
journal: Proc Natl Acad Sci U S A
publication_date: "2024-12-30"\
doi: 0.1073/pnas.2408549121
series_accession: GSE275231\
bioproject: 	PRJNA1150068\
domain: rna_seq\
organism: Homo sapiens\
experiment_type: RNA seq\
platform: Illumina NovaSeq X\
ref_genome: Mus musculus (house mouse) genome assembly GRCm38 (mm10) \
read_type: single_end\
sample_count: 6\
sra_runs_total: 6\
\
samples:\
  Neg_1:\
    condition: Normal kidney group 1\
    sra_runs: [SRX25770698]\
  Neg_2:\
    condition: Normal kidney group 2\
    sra_runs: [SRX25770700]\
  Neg_3:\
    condition: Normal kidney group 3\
    sra_runs: [SRX25770701]\
  Neg_4:\
    condition: Tumor kidney group 1\
    sra_runs: [SRX25770708]\
  Pos_3:\
    condition: Tumor kidney group 2\
    sra_runs: [SRX25770709]\
  Pos_4:\
    condition: Tumpr kidney group 3\
    sra_runs: [SRX25770710]\
\
paths:\
  fastq: fastq/\
  aligned: aligned/\
  counts: counts/\
  logs: logs/\
  qc: qc/\
  reference:\
    bowtie2_index: bowtie2_index/hg38/genome\
    annotation_gtf: clinical_V2_sparsq_V1p2_amplicons.gtf\
\
workflow:\
  threads: 16\
  aligner: bowtie2\
  quantifier: normalizedcounts\
notes: "Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned"}
